Ohio Public Employees Retirement System (OPERS)’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$434K Buy
+177,875
New +$357K ﹤0.01% 1516
2024
Q3
Sell
-57,300
Closed -$134K 2203
2024
Q2
$134K Buy
+57,300
New +$169K ﹤0.01% 1402
2022
Q4
Sell
-51,979
Closed -$561K 1966
2022
Q3
$561K Buy
+51,979
New +$706K ﹤0.01% 1316

Other funds holding ALLO

Ohio Public Employees Retirement System (OPERS)'s ALLO Position: Q1 2026 in Review

Ohio Public Employees Retirement System (OPERS) opened a new position in Allogene Therapeutics (ALLO) in Q1 2026: 177,875 shares worth $434K. The stake represents ﹤0.01% of the portfolio and ranks #1516 among its holdings. This is a return to the name: Ohio Public Employees Retirement System (OPERS) previously reported a position in ALLO as recently as Q2 2024.

Ohio Public Employees Retirement System (OPERS) first reported a position in ALLO in Q3 2022 and has held it in 3 quarters since. The position peaked at $561K in Q3 2022. 208 funds tracked by Wall St. Rank hold ALLO as of Q1 2026.

  • Ohio Public Employees Retirement System (OPERS) held 177,875 shares of Allogene Therapeutics worth $434K as of Q1 2026.
  • Allogene Therapeutics was a new Ohio Public Employees Retirement System (OPERS) position in Q1 2026.
  • Allogene Therapeutics made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q1 2026, its #1516 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Allogene Therapeutics in Q3 2022 and has held it in 3 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Allogene Therapeutics position peaked at $561K in Q3 2022.
  • 208 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q1 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2026, filed 14 May 2026.